John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Surgery Partners
SGRY
$1.83B
| $236K | ﹤0.01% |
+11,529
| New | +$220K |
|
2377
PUT
Southern Copper
SCCO
$181B
| $235K | ﹤0.01% |
+9,825
| New | +$243K |
|
2378
CALL
Stratasys
SSYS
$670M
| $235K | ﹤0.01% |
10,000
+2,000
| +25% | +$52.6K |
|
2379
Cincinnati Financial
CINF
$26.3B
| $234K | ﹤0.01% |
3,960
-14,760
| -79% | -$874K |
|
2380
Collegium Pharmaceutical
COLL
$848M
| $234K | ﹤0.01% |
+8,500
| New | +$179K |
|
|
CLR
2381
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $234K | ﹤0.01% |
+10,185
| New | +$326K |
|
|
FNFV
2382
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $234K | ﹤0.01% |
+20,810
| New | +$231K |
|
2383
Crocs
CROX
$6.03B
| $232K | ﹤0.01% |
+22,650
| New | +$244K |
|
2384
PUT
General Mills
GIS
$21.9B
| $231K | ﹤0.01% |
+4,000
| New | +$230K |
|
2385
PUT
A.O. Smith
AOS
$8.52B
| $230K | ﹤0.01% |
+6,000
| New | +$226K |
|
2386
Dominion Energy
D
$58.6B
| $229K | ﹤0.01% |
3,383
-15,900
| -82% | -$1.1M |
|
|
FBRC
2387
DELISTED
FBR & Co. Common Stock
FBRC
| $229K | ﹤0.01% |
+11,485
| New | +$234K |
|
|
BELFB
2388
Bel Fuse Inc Class B
BELFB
$3.58B
| $228K | ﹤0.01% |
13,192
+2,504
| +23% | +$47.9K |
|
2389
KVH Industries
KVHI
$136M
| $228K | ﹤0.01% |
+24,242
| New | +$235K |
|
|
NILE
2390
DELISTED
Blue Nile, Inc.
NILE
| $228K | ﹤0.01% |
+6,130
| New | +$215K |
|
2391
CALL
Digital Realty Trust
DLR
$69.8B
| $227K | ﹤0.01% |
3,000
-9,000
| -75% | -$649K |
|
2392
CALL
Harley-Davidson
HOG
$2.94B
| $227K | ﹤0.01% |
+5,000
| New | +$246K |
|
|
FNHC
2393
DELISTED
FedNat Holding Company Common Stock
FNHC
| $227K | ﹤0.01% |
+7,695
| New | +$225K |
|
|
QLGC
2394
DELISTED
QLOGIC CORP
QLGC
| $227K | ﹤0.01% |
+18,600
| New | +$225K |
|
2395
Bristol-Myers Squibb
BMY
$137B
| $226K | ﹤0.01% |
3,280
-53,172
| -94% | -$3.51M |
|
|
CYBR
2396
CALL
DELISTED
CyberArk
CYBR
| $226K | ﹤0.01% |
+5,000
| New | +$228K |
|
2397
Rocky Brands
RCKY
$344M
| $226K | ﹤0.01% |
+19,590
| New | +$240K |
|
2398
CALL
Travelers Companies
TRV
$77.3B
| $226K | ﹤0.01% |
2,000
-2,000
| -50% | -$222K |
|
|
LIOX
2399
DELISTED
Lionbridge Technologies
LIOX
| $226K | ﹤0.01% |
+46,021
| New | +$240K |
|
2400
Noodles & Co
NDLS
$93.6M
| $225K | ﹤0.01% |
2,899
+1,052
| +57% | +$100K |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.